Steven Cohen's CRBU Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 15,769 shares of Caribou Biosciences, Inc. (CRBU) worth $27,753, representing 0.00% of the portfolio. First purchased in 2021-Q3, this medium-term investment has been held for 20 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in CRBU, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2023, adding 3.21 M shares. Largest reduction occurred in Q2 2024, reducing 1.24 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Caribou Biosciences (CRBU) Holding Value Over Time
Track share changes against reported price movement
Quarterly Caribou Biosciences (CRBU) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -171,853 | Reduce 91.60% | 15,769 | $1.76 |
| Q1 2026 | -216,316 | Reduce 53.55% | 187,622 | $1.90 |
| Q4 2025 | +115,391 | Add 39.99% | 403,938 | $1.59 |
| Q3 2025 | -1,192 | Reduce 0.41% | 288,547 | $2.33 |
| Q2 2025 | +60,854 | Add 26.59% | 289,739 | $1.26 |
| Q1 2025 | -796,104 | Reduce 77.67% | 228,885 | $0.91 |
| Q4 2024 | -1.11 M | Reduce 51.91% | 1.02 M | $1.59 |
| Q3 2024 | -212,122 | Reduce 9.05% | 2.13 M | $1.96 |
| Q2 2024 | -1.24 M | Reduce 34.63% | 2.34 M | $1.64 |
| Q1 2024 | +63,642 | Add 1.81% | 3.59 M | $5.14 |
| Q4 2023 | +21,543 | Add 0.62% | 3.52 M | $5.73 |
| Q3 2023 | +3.21 M | Add 1107.93% | 3.5 M | $4.78 |
| Q4 2022 | +289,739 | New Buy | 289,739 | $6.28 |
| Q3 2022 | -289,739 | Sold Out | 0 | $0.00 |
| Q3 2021 | +289,739 | New Buy | 289,739 | $23.87 |
Steven Cohen's Caribou Biosciences Investment FAQs
Steven Cohen first purchased Caribou Biosciences, Inc. (CRBU) in Q3 2021, acquiring 289,739 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Caribou Biosciences, Inc. (CRBU) for 20 quarters since Q3 2021.
Steven Cohen's largest addition to Caribou Biosciences, Inc. (CRBU) was in Q3 2023, adding 3,499,833 shares worth $16.73 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 15,769 shares of Caribou Biosciences, Inc. (CRBU), valued at approximately $27,753.
As of the Q2 2026 filing, Caribou Biosciences, Inc. (CRBU) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Caribou Biosciences, Inc. (CRBU) was 3,585,018 shares, as reported at the end of Q1 2024.